29 results on '"Watson D"'
Search Results
2. P112 Variation in eligibility to highly effective modulator therapy between ethnic groups at our centre and how this is reflected in median lung function
3. P391 “I’m different”: reviewing outpatient psychology support for people of colour in an inner London adult cystic fibrosis centre
4. P320 Comparing faecal elastase, pancreatic enzyme doses, HbA1c and insulin doses in adult cystic fibrosis patients pre- and 6 months postcommencement of Kaftrio®
5. WS09.06 A questionnaire to gain an understanding of adherence to inhaled therapies, airway clearance and exercise since commencing the triple combination modulator in cystic fibrosis
6. P165 Exploring weight change and subjective experiences on Kaftrio® in adults with cystic fibrosis
7. P206 A questionnaire to gain an understanding of adherence to inhaled therapies, airway clearance and exercise since commencing the triple combination modulator in cystic fibrosis
8. P219 Establishing a review process for patients using non-invasive ventilation for airway clearance in the St. Bartholomew’s cystic fibrosis adult population
9. P222 To assess measured frailty compared to multidisciplinary perception of frailty in the adult cystic fibrosis population
10. ePS2.02 Comparison of FEV on a remote spirometry device with hospital software in an adult cystic fibrosis cohort
11. WS03.06 Does the use of modulator therapies in adults with cystic fibrosis have a long-term impact on the requirement for intravenous antibiotics
12. 210: Food insecurity screening in adults with cystic fibrosis: A single-center study in the UK
13. 21: Review of glycaemic control, nutritional status and lung function after initiation of flash glucose monitoring for patients with cystic fibrosis–related diabetes
14. WS14.2 Potential factors influencing reduced requirements for intravenous antibiotics during the COVID-19 pandemic
15. P164 What is the tolerance of antibiotic dry powder inhalers in patientswith cystic fibrosis?
16. P174 The association between body composition and respiratory outcomes for patients with cystic fibrosis
17. P263 Are cystic fibrosis patients displaying exacerbation symptoms when they culture new pathogens on respiratory samples?
18. P087 Levelling the playing field through the London Network of the UK Clinical Trials Accelerator Platform
19. Fair selection of participants in clinical trials: The challenge to push the envelope further
20. P334 Advanced care planning in cystic fibrosis: current practice in UK centres
21. P365 Comparison of the incremental Shuttle Walk Test for adult subjects with cystic fibrosis in two formats: hallway versus treadmill
22. 190 Antibiotic allergy testing in adult patients with cystic fibrosis: a single-centre experience
23. 387 Exploring outpatient clinic attendance in adults with CF: what influences attendance?
24. 200 Evaluation of the use of megestrol acetate (MA) in adults with cystic fibrosis (CF)
25. 207 Effect of high-dose cholecalciferol supplementation (HCDS) on serum vitamin D concentrations in adults with cystic fibrosis (CF)
26. 309 The use of a volumetric infusion device for intravenous antibiotic desensitisation in cystic fibrosis
27. 305 Comparison of contacts to adult and paediatric cystic fibrosis Clinical Nurse Specialists
28. Long term outcome of liver transplantation (LT) for patients with cystic fibrosis liver disease (CFLD)
29. P099 The London CTAP network standard operating procedure for averting medications prohibited during clinical trials in cystic fibrosis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.